Medethics Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
- Paid Up Capital ₹ 2.80 M
- Company Age 15 Year, 2 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.60 M
- Satisfied Charges ₹ 1.20 Cr
- Revenue Growth -40.22%
- Profit Growth 18.79%
- Ebitda 15.03%
- Net Worth 0.22%
- Total Assets -17.55%
About Medethics Pharmaceuticals
Medethics Pharmaceuticals Private Limited (MPPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 February 2010 and has a history of 15 years. Its registered office is in Bhubaneswar, Orissa, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 2.80 M.
The company currently has active open charges totaling ₹6.60 M. The company has closed loans amounting to ₹1.20 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sumanta Das and Kusum Das serve as directors at the Company.
Company Details
-
Location
Bhubaneswar, Orissa, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U51397OR2010PTC011609
-
Company No.
011609
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
11 Feb 2010
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Cuttack
Industry
Who are the key members and board of directors at Medethics Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sumanta Das
|
Director | 11-Feb-2010 | Current |
|
Kusum Das
|
Director | 11-Feb-2010 | Current |
Financial Performance of Medethics Pharmaceuticals.
Medethics Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 40.22% decrease. The company also saw a substantial improvement in profitability, with a 18.79% increase in profit. The company's net worth moved up by a moderate rise of 0.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medethics Pharmaceuticals?
In 2023, Medethics Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Kd Corporation (India) Private LimitedSumanta Das and Kusum Das are mutual person
-
S2 Corporation Private Limited
Sumanta Das and Kusum Das are mutual person
Charges (Loans)
₹6.60 M
₹12.00 M
Charges Breakdown by Lending Institutions
- Indian Bank : 0.66 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Aug 2022 | Indian Bank | ₹6.60 M | Open |
| 06 Feb 2013 | Allahabad Bank | ₹1.20 Cr | Satisfied |
How Many Employees Work at Medethics Pharmaceuticals?
Unlock and access historical data on people associated with Medethics Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medethics Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medethics Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
